Introduction to Novel Technology
The increasing demands placed upon trace nucleic acid detection technologies have driven the development and application of novel technologies that have the potential to reliably detect single target nucleic acid molecules within challenging matrices.
It has proven difficult in the past to identify and separate biomolecules at very low concentrations. However, recent developments have improved the sensitivity of detection such that single-molecule detection has been achieved. The ability to detect such low concentrations of DNA will have applications in many fields including medical diagnosis and forensic analysis.
Current trace detection technologies are predominantly nucleic amplification based, employing core methodologies such as the polymerase chain reaction (PCR), which have the potential of amplifying a single target molecule. However, an amplification-based approach suffers from specific drawbacks such as cross amplification and matrix effects.
Emerging trace nucleic acid detection technologies hold the promise of enhanced sensitivities without prior target amplification. Single molecule detection represents the ultimate sensitivity limit in biochemical analysis. However, the developmental nature of these technologies means that few are currently in routine use or commercially available.